| abstract |
EMT, such as furo [3,2-c] pyridine and thieno [3,2-c] pyridine compounds of formula (I), and pharmaceutically acceptable salts, preparations, intermediates, pharmaceutical compositions thereof, and cancer Use in the treatment of diseases such as a condition mediated by protein kinase activity such as RON and / or MET. |